Oak Ridge Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $808K | Sell |
1,816
-17
| -0.9% | -$7.57K | 0.06% | 125 |
|
|
2025
Q1 | $889K | Sell |
1,833
-75
| -4% | -$36.4K | 0.07% | 118 |
|
|
2024
Q4 | $768K | Buy |
1,908
+81
| +4% | +$32.6K | 0.06% | 125 |
|
|
2024
Q3 | $850K | Buy |
1,827
+5
| +0.3% | +$2.33K | 0.07% | 119 |
|
|
2024
Q2 | $854K | Sell |
1,822
-77
| -4% | -$36.1K | 0.08% | 121 |
|
|
2024
Q1 | $794K | Sell |
1,899
-16
| -0.8% | -$6.69K | 0.08% | 127 |
|
|
2023
Q4 | $779K | Sell |
1,915
-32
| -2% | -$13K | 0.09% | 128 |
|
|
2023
Q3 | $677K | Sell |
1,947
-251
| -11% | -$87.3K | 0.09% | 129 |
|
|
2023
Q2 | $773K | Buy |
+2,198
| New | +$773K | 0.1% | 129 |
|
|
2021
Q1 | – | Sell |
-14,968
| Closed | -$3.54M | – | 182 |
|
|
2020
Q4 | $3.54M | Sell |
14,968
-6,027
| -29% | -$1.42M | 0.31% | 103 |
|
|
2020
Q3 | $5.71M | Sell |
20,995
-300
| -1% | -$81.6K | 0.44% | 81 |
|
|
2020
Q2 | $6.18M | Sell |
21,295
-335
| -2% | -$97.3K | 0.52% | 76 |
|
|
2020
Q1 | $5.15M | Sell |
21,630
-163
| -0.7% | -$38.8K | 0.53% | 74 |
|
|
2019
Q4 | $4.77M | Sell |
21,793
-938
| -4% | -$205K | 0.35% | 95 |
|
|
2019
Q3 | $3.85M | Buy |
22,731
+549
| +2% | +$93K | 0.29% | 99 |
|
|
2019
Q2 | $4.07M | Sell |
22,182
-2,717
| -11% | -$498K | 0.28% | 103 |
|
|
2019
Q1 | $4.58M | Buy |
+24,899
| New | +$4.58M | 0.29% | 106 |
|